A Dose Escalation and Safety Study of I5NP to Prevent Acute Kidney Injury (AKI) in Patients at High Risk of AKI Undergoing Major Cardiovascular Surgery (QRK.004)
Clinical trial NCT00683553 · TERMINATED
Trial details
- NCT number
- NCT00683553
- Sponsor
- Quark Pharmaceuticals
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2008-05-01
- Primary completion
- 2010-05-01
- Enrollment
- 3
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.